This finding clearly indicates that even in the presence of saturated SHH level in the NSCLC cells, expression of IL-24 only inhibits at the level of GLI1 expression, without affecting other components of the SHH pathway. The gene discussed is IL24; the disease is non-small cell lung carcinoma.